Infections clinical trials
The registry lists 2,097 studies for Infections across more than 10 countries. 361 are recruiting or about to start. 820 of them are mainly about Infections (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-18. Counting its 275 narrower conditions too, such as COVID-19: 51,363 studies, 6,732 open.
ClinicalTrials.gov finds 51,427 studies for Infections. How that becomes 2,096 hereChecked on ClinicalTrials.gov . The studies here are updated every night.
This page counts the studies the registry files under Infections, and those it files under no condition that list Infectionsthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. Only this comparison waits for its turn: it is asked again about once a week, so between two checks the registry's number can run a little ahead of it. How condition pages count
- 51,427Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
- −44,251Filed under a narrower condition, counted on its own pageCOVID-19 7,492 · HIV Infections 4,599 · Sepsis 2,115 · Influenza, Human 1,981 · Acquired Immunodeficiency Syndrome 1,757 · Hepatitis C 1,517 · 256 more
- −2,786List Infections as a condition, but the registry did not file them under itMost often written as “Helicobacter Pylori Infection” (393), “HIV-1-infection” (247), and “HIV-1 Infection” (177). The registry filed 1,837 of them under no condition at all, and the others under other conditions only, most often Stomach Neoplasms (35) and Vaginitis (21).
- −2,294Match it another way1,415 name it in the title, 244 in a keyword, and 635 by a synonym or other text the search reads.
- 2,096The count on this page
Get an email when these change. Save the Infections studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Status
Who runs them
ViiV Healthcare (123) · National Institute of Allergy and Infectious Diseases (NIAID) (42) · GlaxoSmithKline (40) · Assistance Publique - Hôpitaux de Paris (23) · Pfizer (18) · Brigham and Women's Hospital (15) · University of Pittsburgh (13) · University of North Carolina, Chapel Hill (12)
What is being tested here
Drugs under test in Infections studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Drug classes tested here Beta-lactamase inhibitors 5 open · Reverse transcriptase inhibitors 1 open · Corticosteroids 1 open · NSAIDs 1 open · Integrase inhibitors 61
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest, phase 3 first
- Dec 2026Immunogenicity and Safety of HPV-4 Vaccine With or Without Td Vaccine in Children · Phase 3 · PT Bio Farma
- Mar 2027Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Starting Immunoglobulin (Start Ig) · Phase 3 · Monash University
- Mar 2027Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT) · Phase 3 · Monash University
- Mar 2027Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig) · Phase 3 · Monash University
- Mar 2027Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig) · Phase 3 · Monash University
- Apr 2027Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension · Phase 3 · Monash University
- Apr 2027A Study of COVID-19 Vaccine(s) in Children and Adults · Phase 3 · BioNTech SE
- Sep 2027A Study to Evaluate Efficacy, Immunogenicity and Safety of a Recombinant Respiratory Syncytial Virus Vaccine in Older Adults Aged 60 Years and Older · Phase 3 · Guangzhou Patronus Biotech Co., Ltd.
- Sep 2027PO vs IV Antibiotics for the Treatment of Infected Nonunion of Fractures After Fixation · Phase 3 · Major Extremity Trauma Research Consortium
- Sep 2027A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised · Phase 3 · Pfizer
Who these studies take
Of the 262 Infections studies recruiting now, 144 (55%) set no upper age limit and 84 (32%) stop at 75 or younger. 86 (33%) take children under 18. 20 (8%) are for women only and 3 (1%) for men only; 64 (24%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 61 (23%) | 60 (23%) |
| 18 | 207 (79%) | 194 (74%) |
| 30 | 210 (80%) | 193 (74%) |
| 40 | 212 (81%) | 195 (74%) |
| 50 | 207 (79%) | 193 (74%) |
| 65 | 197 (75%) | 187 (71%) |
| 75 | 182 (69%) | 173 (66%) |
| 85 | 173 (66%) | 163 (62%) |
Across all 2,097 studies, recruiting or not: 32% stop at 75 or younger and 28% at 65; 30% take children; 7% are for women only and 2% for men only; 27% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Infections studies take
Of 78 phase 1 interventional studies under Infections, half reached primary completion within 10 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Phase 1 | 10 mo3–20 · 78 studies | 6 mo2–13 · 51 studies | — |
| Phase 2 | 16 mo10–47 · 77 studies | 14 mo9–19 · 42 studies | 24 mo14–58 · 35 studies |
| Phase 3 | 30 mo17–53 · 76 studies | 25 mo15–33 · 42 studies | — |
| Phase 4 | 27 mo15–68 · 75 studies | — | 27 mo15–68 · 69 studies |
| Interventional, no phase | 24 mo9–50 · 308 studies | — | 24 mo9–51 · 276 studies |
| Observational | 35 mo18–67 · 300 studies | 20 mo7–50 · 38 studies | 36 mo20–79 · 262 studies |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 19, 2026.
Started recruiting7
- Gastrointestinal Symptoms and Tolerance in Infants Fed Goat or Cow's Milk-based Infant FormulaNov 18, 2026NCT07342972
- TDAP in Burn Patients (Group 2)Nov 17, 2026NCT07223684
- Surgical Critical Care Initiative (SC2i) Tissue and Data Acquisition Protocol (TDAP) in Burn Patients Improving the Robustness and Generalizability of Post-burn Sepsis Prediction With the Post-Burn Sepsis Digital Twin. Group 1Nov 17, 2026NCT07249762
- Collection of Venous and Capillary Blood Samples Research, Optimization and Calibration of New Diagnostic DevicesNov 17, 2026NCT07378514
- Why Do People With Epilepsy Get More Infections?Nov 10, 2026NCT07903168
Show 2 moreShow fewer
Results posted1
- Improving Post-discharge Antimicrobial UseNov 9, 2026NCT05471726
Stopped2
- Nutritional Therapy Enriched With Omega-3 in Patients With Lung ResectionSuspendedNov 13, 2026NCT06531460
- Cryptosporidium Infection and Human Colorectal CancerTerminatedNov 6, 2026NCT04332705
Newly registered10
- The PRECISION Partners Platform (P3) StudyNov 18, 2026NCT07944183
- Immune Response Profiling in SepsisNov 16, 2026NCT07937839
- Pharmacist-Led Antimicrobial Therapy Optimization in Intermediate CareNov 16, 2026NCT07940088
- The LITTLE OWLS Study (in German: "Kleine Eulen OWL"): Exploring the Early-life Microbiome Development and Physical and Mental Health Outcomes During Childhood.Nov 13, 2026NCT07934654
- Viscoelastic Coagulation Monitoring for Early Identification of Sepsis: The VISION II StudyNov 10, 2026NCT07927621
Show 5 moreShow fewer
- A Study to Evaluate Efficacy, Immunogenicity and Safety of a Recombinant Respiratory Syncytial Virus Vaccine in Older Adults Aged 60 Years and OlderNov 2, 2026NCT07908654
- Why Do People With Epilepsy Get More Infections?Oct 29, 2026NCT07903168
- Microbiota Changes Related to Outcomes in Kidney TransplantationOct 26, 2026NCT07893691
- Phase 1 Trial to Evaluate Safety and Immunogenicity of MVA-BN-EBV in Healthy Young AdultsOct 22, 2026NCT07888088
- Novel Antimicrobial Solution to Prevent InfectionsOct 19, 2026NCT07881822
Studies
Recruiting first, then most recently updated. Showing 50 of 2,097. Browse all 2,097 → or search them.
- A Phase 2 Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy ParticipantsNot yet recruitingNCT07205796Phase 2
- Gastrointestinal Symptoms and Tolerance in Infants Fed Goat or Cow's Milk-based Infant FormulaRecruitingNCT07342972Not applicable1 country
- The PRECISION Partners Platform (P3) StudyRecruitingNCT079441831 country
- PO vs IV Antibiotics for the Treatment of Infected Nonunion of Fractures After FixationRecruitingNCT05699174Phase 31 country
- Clinical Assessment and Treatment in the Nursing Home as an Alternative to Hospital AdmissionRecruitingNCT07756554Not applicable1 country
- GMPA Versus PPI for Gastric Protection and aGVHD RiskRecruitingNCT07791849Not applicable1 country
- Surgical Critical Care Initiative (SC2i) Tissue and Data Acquisition Protocol (TDAP) in Burn Patients Improving the Robustness and Generalizability of Post-burn Sepsis Prediction With the Post-Burn Sepsis Digital Twin. Group 1RecruitingNCT072497621 country
- Collection of Venous and Capillary Blood Samples Research, Optimization and Calibration of New Diagnostic DevicesRecruitingNCT073785141 country
- TDAP in Burn Patients (Group 2)RecruitingNCT072236841 country
- Immune Response Profiling in SepsisRecruitingNCT079378391 country
- Study of ICG Fluorescence Imaging in Open Fracture and Infection PatientsRecruitingNCT067936441 country
- New Diagnostic Tool (MinION) for Identifying Microorganisms in Foot Wounds of Patients Living With Diabetic Foot OsteomyelitisRecruitingNCT073919951 country
- The LITTLE OWLS Study (in German: "Kleine Eulen OWL"): Exploring the Early-life Microbiome Development and Physical and Mental Health Outcomes During Childhood.RecruitingNCT079346541 country
- Evaluation, Treatment, and Follow-up of Patients With Lyme DiseaseRecruitingNCT000280801 country
- Diagnosis and Management of Inflammatory and Infectious DiseasesRecruitingNCT005577261 country
- Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)RecruitingNCT000061501 country
- Shortened Regimen for Drug-susceptible TB in ChildrenRecruitingNCT06253715Phase 37 countries
- Detection and Characterization of Host Defense DefectsRecruitingNCT000013551 country
- Viscoelastic Coagulation Monitoring for Early Identification of Sepsis: The VISION II StudyNot yet recruitingNCT079276211 country
- Why Do People With Epilepsy Get More Infections?RecruitingNCT079031681 country
- Inflammatory and Infectious Diseases of the Nervous SystemRecruitingNCT024358101 country
- NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)RecruitingNCT05189925Phase 11 country
- Pathogenesis and Genetics of Disseminated or Refractory CoccidioidomycosisRecruitingNCT021902661 country
- Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and GranulocytesRecruitingNCT000014051 country
- Evaluation of Patients With Immune Function AbnormalitiesRecruitingNCT001289731 country
- A Study to Compare the Efficacy and Safety of Extended and Intermittent Infusion of Beta-lactams in Critically Ill Paediatric PatientsRecruitingNCT07484633Phase 41 country
- A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)RecruitingNCT07266831Phase 2/39 countries
- A Study to Evaluate Efficacy, Immunogenicity and Safety of a Recombinant Respiratory Syncytial Virus Vaccine in Older Adults Aged 60 Years and OlderNot yet recruitingNCT07908654Phase 31 country
- KInetics of Procalcitonin to Reduce Unnecessary aNtibiotic Use - Comparing Procalcitonin Kinetics-guided and Absolute Procalcitonin Value-guided Antibiotic Initiation in Reducing Unnecessary Antibiotic Use in Critically Ill PatientsRecruitingNCT07211620Not applicable1 country
- CONTinuous Infusion Versus Intermittent Dosing of ceftaZidime/AVIbactam in Critically Ill PatientsRecruitingNCT06811727Phase 41 country
- Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental OxygenRecruitingNCT05624450Phase 339 countries
- Evaluation and Long-Term Follow-up of Patients With Inflammatory DisordersEnrolling by invitationNCT000013511 country
- POS-ARI-ER Observational Study of Acute Respiratory InfectionsRecruitingNCT0581423710 countries
- Investigation of the Delve Detect Cerebrospinal Fluid (CSF) Metagenomic Next-generation Sequencing (mNGS) Test When Used for the Initial Diagnostic Workup of Patients With Suspected Central Nervous System (CNS) InfectionRecruitingNCT07435649Not applicable1 country
- Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe RegionsRecruitingNCT07654283Phase 26 countries
- Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent InfectionsRecruitingNCT07220915Phase 37 countries
- High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) RecipientsRecruitingNCT05947071Phase 21 country
- Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordRecruitingNCT017931681 country
- A Cohort Study on Anti-microbial Stewardship in PICUNot yet recruitingNCT05862688
- Microbiota Changes Related to Outcomes in Kidney TransplantationNot yet recruitingNCT078936911 country
- Comparison of Sepsis Prediction AlgorithmsNot yet recruitingNCT059439381 country
- Novel Antimicrobial Solution to Prevent InfectionsNot yet recruitingNCT07881822
- Phase 1 Trial to Evaluate Safety and Immunogenicity of MVA-BN-EBV in Healthy Young AdultsNot yet recruitingNCT07888088Phase 11 country
- A Study to Evaluate the Efficacy and Safety of Combination Therapy of BRII-179, BRII-835 and PEG-IFNα in Participants With Chronic Hepatitis B Virus (HBV) Infection (ENHANCE)RecruitingNCT06650852Phase 21 country
- The Immune Responses After Hepatitis B Revaccination Doses in a Young CohortRecruitingNCT04970836Not applicable1 country
- UNC Pleural Fluid RegistryRecruitingNCT056203291 country
- Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)RecruitingNCT05947955Phase 213 countries
- Naproxen Versus Placebo as Adjunct Treatment of CellulitisNot yet recruitingNCT07665476Phase 31 country
- Prediction and Prevention of Bloodstream Infections After Kidney TransplantationNot yet recruitingNCT07407673Phase 31 country
- Rechallenge With a Low Pathogenicity Avian H10N7 Influenza Virus in Healthy Human Volunteers Previously Challenged With H10N7 InfluenzaEnrolling by invitationNCT07215871Phase 11 country